✦ LIBER ✦

Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy

✍ Scribed by Theyer, G; Holub, S; Dürer, A; Andert, S; Haberl, I; Theyer, U; Hamilton, G

Book ID: 109837396
Publisher: Nature Publishing Group
Year: 1997
Tongue: English
Weight: 751 KB
Volume: 75
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1997.259

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Measurements of free and total PSA, tiss

Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgen suppression therapy

✍ Theyer, Gerhard; D�rer, Alexander; Theyer, Ulrike; Haberl, Ines; Ulsperger, Erns 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

BACKGROUND. The present study evaluated monthly measurements of free and total prostate-specific antigen (PSA), and the tumor proliferation markers tissue polypeptide-specific antigen (TPS) and cytokeratin fragment 21-1 (CYFRA 21-1) in patients with advanced prostate cancer receiving intermittent an

Effects of intermittent androgen suppres

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

✍ Koichiro Akakura; Nicholas Bruchovsky; S. Larry Goldenberg; Paul S. Rennie; Anne 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 782 KB

The change in free-to-total prostate-spe

The change in free-to-total prostate-specific antigen during progression to androgen-independent state in prostate cancer patients: utilization for intermittent androgen suppression therapy

✍ Akakura, K 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 36 KB

Tissue concentrations of tissue polypept

Tissue concentrations of tissue polypeptide antigen (TPA) and prostatic specific antigen (PSA) in 42 patients with prostatic carcinoma

✍ Mirtha Grande; Kjell Carlström; Barbro Lundh Rozell; Peter Eneroth; Reinhard Ste 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

Influence of body mass index on prostate

Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer

✍ Jason A. Efstathiou; Ming-Hui Chen; Andrew A. Renshaw; Marian J. Loffredo; Antho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Abstract ## BACKGROUND Increasing body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure after radical prostatectomy. Whether BMI is associated with time to PSA failure was investigated in men treated with androgen suppression therapy (AST) and radiatio

Time to an undetectable prostate-specifi

Time to an undetectable prostate-specific antigen (PSA) after androgen suppression therapy for postoperative or postradiation PSA recurrence and prostate cancer-specific mortality

✍ Anthony V. D'Amico; David G. McLeod; Peter R. Carroll; Jennifer Cullen; Ming-Hui 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract ## BACKGROUND For men receiving androgen‐suppression therapy (AST) for a rising postoperative or postradiation prostate‐specific antigen (PSA) recurrence, whether the time to an undetectable (u) PSA was significantly associated with prostate cancer‐specific mortality (PCSM) was evaluat